------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------------------------
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
December 3, 2002
Date of Report
BAXTER INTERNATIONAL INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-4448 36-0781620
------------------------ ---------------------------------
(Commission file number) (IRS Employer Identification No.)
One Baxter Parkway, Deerfield, Illinois 60015
--------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (847) 948-2000
---------------------------------------------------------------------
Page 1 of 5
Item 5. Other Events.
On December 3, 2002, Baxter International Inc. issued the attached press release
announcing its intent to divest the majority of the services component of its
Renal business and focus primarily on the products used in the treatment of
kidney disease. The press release is filed as Exhibit 99 and incorporated by
reference.
Item 7. Exhibits.
99 Press Release dated December 3, 2002
Page 2 of 5
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
BAXTER INTERNATIONAL INC.
-------------------------
(Registrant)
By: /s/ Jan Stern Reed
---------------------
Jan Stern Reed
Corporate Secretary
Date: December 3, 2002
Page 3 of 5